genet
divers
orthocoronavirina
cov
famili
prone
cross
speci
transmiss
diseas
emerg
human
livestock
virus
similar
known
epidem
strain
circul
wild
domest
anim
increas
probabl
emerg
futur
current
approv
therapeut
human
cov
present
clear
unmet
medic
need
remdesivir
rdv
monophosphoramid
prodrug
adenosin
analog
potent
activ
array
rna
viru
famili
includ
filovirida
paramyxovirida
pneumovirida
orthocoronavirina
target
viral
rna
depend
rna
polymeras
rdrp
develop
multipl
assay
defin
breadth
rdv
antivir
activ
cov
famili
show
potent
antivir
activ
rdv
endem
human
cov
submicromolar
ec
valu
known
cov
member
deltacoronaviru
genu
diverg
rdrp
compar
sarsand
merscov
avian
porcin
member
harbor
nativ
residu
rdrp
confer
resist
betacov
nevertheless
rdv
highli
efficaci
porcin
deltacoronaviru
pdcov
data
extend
known
breadth
antivir
activ
rdv
includ
contemporari
human
highli
diverg
zoonot
cov
potenti
enhanc
abil
fight
futur
emerg
cov
genet
divers
orthocoronavirina
cov
famili
divid
four
genera
alpha
beta
gamma
deltacoronaviru
thu
far
human
cov
limit
alpha
beta
genera
human
cov
caus
upper
lower
respiratori
tract
infect
typic
present
commoncold
like
symptom
caus
sever
diseas
young
children
well
peopl
underli
respiratori
condit
ie
asthma
copd
elderli
dijkman
et
al
falsey
et
al
children
sever
respiratori
tract
cov
infect
requir
hospit
case
associ
febril
seizur
less
year
old
carman
et
al
heimdal
et
al
cov
infect
also
sever
elderli
requir
hospit
even
caus
acut
respiratori
distress
syndrom
ard
falsey
et
al
vassilara
et
al
zoonot
cov
natur
predilect
emerg
new
host
speci
give
rise
new
diseas
recent
exemplifi
human
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
de
wit
et
al
interestingli
known
human
cov
thought
emerg
zoonos
wild
domest
anim
hu
et
al
huynh
et
al
menacheri
et
al
vijgen
et
al
emerg
paradigm
uniqu
human
cov
novel
anim
cov
like
porcin
epidem
diarrhea
viru
pedv
porcin
delta
coronaviru
pdcov
swine
acut
diarrhea
syndrom
coronaviru
sadscov
recent
emerg
caus
death
million
piglet
billion
dollar
agricultur
loss
hu
et
al
huang
et
al
zhou
et
al
chloroquin
ribavirin
lopinavir
interferon
test
multipl
cov
vitro
current
approv
therapeut
human
cov
chan
et
al
de
wild
et
al
shen
et
al
address
unmet
medic
need
treatment
current
human
cov
infect
maxim
pandem
prepared
broad
spectrum
antivir
therapi
need
effect
current
futur
emerg
cov
given
numer
exampl
novel
cov
emerg
remdesivir
rdv
monophosphoramid
prodrug
adenosin
analog
demonstr
antivir
activ
array
rna
viru
famili
includ
filovirida
paramyxovirida
pneumovirida
cov
sheahan
et
al
warren
et
al
antivir
mechan
rdv
demonstr
delay
chain
termin
nascent
viral
rna
ebola
viru
nipah
viru
respiratori
syncyti
viru
lo
et
al
tchesnokov
et
al
tchesnokov
et
al
warren
et
al
previous
report
antivir
activ
rdv
genet
divers
panel
human
endem
emerg
zoonot
cov
includ
alpha
mous
hepat
viru
mhv
beta
sarscov
relat
bat
cov
beta
well
merscov
relat
bat
cov
beta
agostini
et
al
sheahan
et
al
upon
passag
mhv
presenc
rdv
resist
mutat
aris
rna
depend
rna
polymeras
rdrp
confer
resist
ie
shift
ec
demonstr
rdrp
target
rdv
antivir
activ
agostini
et
al
cov
rdrp
highli
conserv
within
genogroup
ie
beta
amino
acid
ident
group
vari
sheahan
et
al
expand
upon
earlier
work
better
understand
spectrum
rdv
efficaci
among
human
zoonot
cov
show
rdv
inhibit
endem
human
cov
well
member
deltacoronaviru
genu
pdcov
diverg
rdrp
known
cov
compar
sarsand
merscov
data
illumin
breadth
antivir
activ
rdv
cov
famili
suggest
rdv
potenti
antivir
current
endem
epidem
cov
well
futur
emerg
cov
human
colorect
carcinoma
cell
purchas
american
type
cultur
collect
atcc
manassa
va
maintain
thermofish
scientif
fetal
bovin
serum
fb
hyclon
thermofish
scientif
antibiot
antimycot
antianti
gibco
thermofish
scientif
human
hepatoma
cell
kindli
provid
dr
mark
heis
unc
chapel
hill
cell
grown
dulbecco
modifi
eagl
medium
dmem
gibco
thermofish
scientif
fb
hyclon
antianti
gibco
thermofish
scientif
porcin
kidney
cell
purchas
unc
tissu
cultur
facil
maintain
dmem
fetal
clone
hyclon
thermofish
scientif
nonessenti
amino
acid
neaa
gibco
thermofish
scientif
mm
hepe
gibco
thermofish
scientif
antianti
gibco
thermofish
scientif
human
lung
fibroblast
cell
purchas
atcc
maintain
mem
gibco
fb
hyclon
thermofish
scientif
antianti
gibco
thermofish
scientif
strain
purchas
atcc
passag
cell
amplifi
cell
creat
work
stock
strain
purchas
atcc
passag
cell
amplifi
cell
creat
work
stock
porcin
deltacoronaviru
pdcov
strain
llcpk
kindli
provid
dr
linda
saif
ohio
state
univers
pdcov
viru
stock
creat
passag
cell
optimem
gibco
thermofish
scientif
neaa
gibco
thermofish
scientif
mm
hepe
gibco
thermofish
scientif
antianti
gibco
tryptos
phosphat
broth
pancreatin
sigmaaldrich
st
loui
mo
rdv
synthes
gilead
scienc
inc
chemic
ident
puriti
determin
nuclear
magnet
reson
highresolut
mass
spectrometri
highperform
liquid
chromatographi
hplc
analysi
rdv
made
avail
univers
north
carolina
chapel
hill
unc
materi
transfer
agreement
gilead
scienc
rdv
solubil
dmso
vitro
studi
polyl
lysin
gibco
thermofish
scientif
coat
plate
seed
cellswel
follow
day
cell
infect
moi
dilut
infect
medium
dmem
fb
antianti
thermofish
scientif
presenc
dmso
dose
respons
rdv
h
h
cell
overlaid
optimem
gibco
thermofish
scientif
carboxymethyl
cellulos
fb
neaa
antianti
contain
dmso
dose
respons
rdv
final
dmso
concentr
held
condit
four
eight
replic
well
allot
condit
noninfect
cell
treat
dmso
also
includ
inhibit
control
h
treatment
cell
fix
buffer
formalin
thermofish
scientif
permeabil
triton
sigmaaldrich
st
loui
mo
block
pb
skim
milk
endogen
peroxidas
quench
hydrogen
peroxid
thermofish
scientif
antigen
stain
antibodi
primari
mous
nucleoprotein
antibodi
millipor
secondari
goat
antimous
hrp
antibodi
kpl
visual
dab
reagent
thermofish
scientif
infect
cell
foci
visual
quantit
via
ctl
immunospot
elispot
reader
ctl
cleveland
oh
usa
effect
concentr
reach
decreas
viral
replic
defin
ec
valu
ec
valu
calcul
doserespons
curv
use
variabl
slope
equat
equat
graphpad
prism
graphpad
logec
x
hillslop
repres
inhibit
x
repres
rdv
concentr
mock
infect
cell
use
control
inhibit
cell
treat
vehicl
alon
use
control
inhibit
antivir
fluoresc
situ
hybrid
fish
imag
assay
plate
calf
skin
collagen
sigmaaldrich
st
loui
mo
coat
glass
cover
slip
mm
round
neuvitro
thermofish
scientif
seed
cellswel
h
prior
infect
cell
infect
moi
dilut
infect
medium
contain
either
rdv
dmso
vehicl
control
h
h
monolay
wash
infect
medium
contain
previous
describ
dmso
rdv
ad
day
coverslip
fix
formaldehyd
pb
min
wash
pb
store
ethanol
stain
uniqu
oligonucleotid
probe
coupl
quasar
fabric
lgc
biosearch
technolog
fix
coverslip
fish
stain
nuclei
counterstain
hoechst
thermofish
scientif
accord
protocol
provid
lgc
coverslip
imag
keyenc
autom
microscop
imag
acquir
set
cell
quantit
perform
use
keyenc
hybrid
cell
count
analysi
packag
matsuda
et
al
genom
subgenom
qrtpcr
assay
plate
cell
prepar
without
coverslip
infect
treat
similarli
describ
fish
day
total
rna
isol
via
qiagen
rneasi
kit
quantifi
nanodrop
thermo
store
analysi
previous
publish
taqman
style
primetim
qrtpcr
assay
gener
integr
dna
technolog
idt
measur
genom
rna
forward
gtggattctgctcaag
probe
ibfq
attcacagactgcagaaacagcgcattctgta
revers
aatac
ctttcttggctcgagtaat
subgenom
rna
nucleocapsid
forward
cgatgaggctattccgactaggt
probe
ibfq
tccgcctggcacggtactccct
revers
cttcctgagc
cttcaatatagtaacc
loen
et
al
walsh
et
al
singl
step
qrtpcr
perform
use
fast
viru
master
mix
thermofish
scientif
associ
program
roch
light
cycler
qpcr
machin
reaction
contain
ng
total
rna
experiment
sampl
copi
numberreact
gener
use
rna
standard
curv
day
prior
infect
blackwal
clearbottom
plate
corn
seed
cellswel
cell
infect
moi
dilut
infect
medium
dmem
fb
antianti
presenc
dmso
dose
respons
rdv
incub
day
eight
replic
well
allot
concentr
condit
dmso
held
constant
condit
noninfect
cell
treat
dmso
also
includ
inhibit
control
termin
assay
cytopath
effect
cpe
measur
luminomet
promega
glomax
promega
madison
wi
celltiterglo
assay
promega
madison
wi
day
prior
infect
blackwal
clearbottom
plate
corn
kennebunk
seed
cell
well
cell
infect
pdcov
moi
dilut
infect
medium
dmem
hepe
neaa
antianti
tryptos
phosphat
broth
pancreatin
presenc
rdv
dmso
day
eight
replic
well
allot
concentr
condit
final
dmso
concentr
held
constant
condit
noninfect
cell
treat
dmso
also
includ
inhibit
control
termin
assay
cpe
measur
luminomet
promega
glomax
celltiterglo
assay
promega
perform
similar
antivir
assay
cell
follow
chang
cell
infect
moi
presenc
dmso
dilut
pdcov
infect
medium
day
pdcov
assay
condit
similar
assay
follow
chang
tpck
trypsin
use
rather
pancreatin
cell
infect
pdcov
moi
titer
determin
cell
perform
similar
antivir
assay
cell
use
media
condit
use
pdcov
follow
chang
cell
infect
moi
day
assess
rdv
cytotox
cell
cell
seed
treat
dmso
rdv
dilut
appropri
infect
medium
concurr
antivir
assay
describ
termin
assay
cytox
measur
via
celltiterglo
assay
promega
read
promega
luminomet
cc
valu
defin
concentr
requir
reach
cell
death
determin
fit
doserespons
equat
ec
valu
replac
cc
valu
use
graphpad
prism
cellfre
sampl
use
cytotox
control
vehicleonli
cell
use
cytotox
control
multipl
sequenc
align
phylogenet
tree
construct
use
geneiou
tree
builder
geneiou
http
wwwgeneiouscom
tree
visual
custom
sequenc
ident
heat
map
creation
perform
evolview
www
evolgeniusinfoevolview
access
number
util
phylogenet
analysi
alphacoronaviru
group
pedv
porcin
epidem
diarrhea
viru
alphacoronaviru
group
ec
valu
rdv
previous
report
merscov
cell
primari
human
airway
epitheli
cell
hae
sarscov
hae
mhv
dbt
cell
agostini
et
al
sheahan
et
al
sought
determin
ec
valu
rdv
typic
caus
upper
respiratori
infect
children
caus
sever
lower
respiratori
infect
adult
underli
respiratori
condit
ie
asthma
copd
elderli
falsey
et
al
sinc
caus
overt
cytopath
effect
cpe
cell
establish
focu
form
reduct
assay
ffra
fig
plate
base
nucleocapsid
antigen
stain
fig
quantif
via
elispot
reader
increas
throughput
fig
among
numer
viral
genom
subgenom
messeng
rna
protein
product
gener
cov
replic
nucleocapsid
viral
messeng
rna
protein
abund
consist
observ
rdv
dosedepend
reduct
antigen
foci
fig
e
similarli
ec
mean
standard
deviat
highli
consist
experi
experi
fig
importantli
cc
obtain
cell
thu
assay
system
select
index
si
cc
ec
assay
driven
detect
nucleocapsid
abund
viral
protein
cov
replic
thu
dynam
rang
detect
maxim
due
antibodi
viral
antigen
pair
may
notabl
lower
chosen
measur
express
viral
protein
lower
express
eg
nonstructur
protein
neuman
et
al
convers
due
high
abund
nucleocapsid
mrna
rdv
may
caus
reduct
viral
rna
detect
assay
certain
threshold
achiev
result
signific
diminish
nucleocapsid
protein
product
aim
corrobor
proteinbas
ffra
data
multipl
viral
rnabas
techniqu
first
employ
rna
fluoresc
situ
hybrid
fish
microscopybas
dot
repres
data
one
well
multiwel
plate
line
drawn
mean
error
bar
repres
standard
deviat
f
ec
valu
gener
graph
percent
inhibit
data
graphpad
prism
techniqu
region
genom
rna
stain
uniqu
oligonucleotid
probe
conjug
quasar
fluorophor
rna
fish
visual
fluoresc
microscopi
observ
rdv
dosedepend
reduct
genom
rna
fig
quantifi
trend
cell
number
three
random
microscopi
field
per
drug
condit
determin
autom
enumer
hoechst
stain
nuclei
along
total
fish
areafield
fig
number
nuclei
per
random
field
consist
among
drug
condit
fig
similarli
observ
differ
fish
area
compar
mock
infect
cell
absenc
rdv
highest
dose
rdv
fish
signal
detect
rdv
dose
diminish
viru
replic
gradual
increas
level
similar
untreat
cell
fig
similar
data
gener
concurr
equival
studi
quantit
revers
transcriptas
pcr
qrtpcr
measur
genom
subgenom
nucleocapsid
viral
rna
speci
due
increas
sensit
pcrbase
assay
microscopi
dynam
rang
qrtpcr
assay
log
compar
mock
infect
replic
fig
similar
fish
level
genom
subgenom
rna
treat
rdv
similar
mock
infect
increas
rdv
dose
depend
manner
result
ec
gener
genom
rna
assay
lower
obtain
ffra
unexpect
given
increas
sensit
pcrbase
assay
import
note
qpcr
assay
may
underestim
potenc
rdv
antivir
effect
rdv
report
delay
chain
termin
lo
et
al
tchesnokov
et
al
tchesnokov
et
al
warren
et
al
thu
assay
detect
function
nonfunct
truncat
defect
viral
rna
long
target
sequenc
present
unlik
infect
caus
cpe
thu
establish
cpe
celltiterglobas
antivir
assay
fig
rdv
dosedepend
reduct
replic
observ
fig
without
druginduc
cytotox
fig
five
independ
experi
obtain
averag
ec
mean
standard
deviat
fig
importantli
sinc
cytotox
cc
observ
cell
across
dose
rang
measur
assay
fig
si
assay
genet
divers
cov
famili
infect
wide
varieti
avian
mammalian
host
four
cov
genera
deltacoronaviru
diverg
rna
depend
rna
polymeras
rdrp
compar
sarsand
merscov
amino
acid
similar
sarsor
merscov
fig
interestingli
deltacoronaviru
rdrp
natur
harbor
leucin
residu
associ
partial
resist
ie
shift
ec
rdv
mhv
sarscov
homolog
posit
fig
map
percent
amino
acid
ident
cov
describ
fig
determin
variat
local
one
specif
region
function
domain
fig
variat
across
entir
protein
region
concentr
heterogen
motif
b
nucleotid
bind
c
sdd
motif
activ
site
ctermin
region
thumb
domain
fig
importantli
rdrp
function
domain
ag
describ
xu
et
al
sarscov
fig
highli
conserv
ie
ident
xu
et
al
given
diverg
deltacoronaviru
rdrp
natur
occur
put
resist
mutat
sought
determin
suscept
member
deltacoronaviru
genu
antivir
effect
rdv
use
porcin
deltacoronaviru
pdcov
model
first
establish
antivir
assay
porcin
kidney
epitheli
cell
line
support
robust
pdcov
replic
fig
enter
cov
ie
pdcov
pedv
requir
addit
digest
enzym
ie
trypsin
pancreatin
cultur
medium
effici
replic
cpe
beall
et
al
hu
et
al
cell
serumfre
medium
pancreatin
rdv
diminish
pdcov
replic
greater
thu
ec
could
determin
fig
ascertain
whether
pdcov
natur
resist
rdv
cell
harbor
unknown
defect
cellular
process
requir
antivir
activ
ie
nucleotid
uptak
metabol
etc
perform
similar
antivir
assay
cell
fig
similar
pdcov
rdv
potent
cell
ec
fig
g
yet
antivir
activ
rdv
cell
pdcov
assay
medium
ie
serum
free
medium
trypsin
similar
fig
ec
fig
data
suggest
cell
defici
cellular
process
requir
antivir
activ
rdv
importantli
cell
cultur
tpck
trypsincontain
serumfre
media
fig
pdcov
replic
dosedepend
reduc
fig
ec
valu
fig
j
k
cc
valu
si
togeth
previou
public
data
demonstr
panel
cov
repres
familywid
genet
divers
rdrp
suscept
inhibit
rdv
effect
broadspectrum
therapi
need
emerg
viral
threat
today
like
ebola
merscov
well
yet
emerg
multipl
exampl
novel
cov
emerg
includ
six
human
cov
thought
emerg
zoonos
hu
et
al
huynh
et
al
menacheri
et
al
vijgen
et
al
unlik
sarsand
merscov
known
caus
sporad
outbreak
four
human
cov
endem
caus
annual
widespread
morbid
infant
elderli
potenti
requir
hospit
carman
et
al
falsey
et
al
varghes
et
al
although
rare
endem
human
cov
like
also
caus
sever
respiratori
diseas
pneumonia
ard
etc
subset
patient
present
similar
sarsand
merscov
falsey
et
al
patrick
et
al
vassilara
et
al
thu
capac
human
cov
caus
sever
diseas
uniqu
emerg
virus
like
sarsand
merscov
cov
specif
antivir
approv
human
use
mani
approv
therapi
indic
evalu
cov
hope
repurpos
antimalari
chloroquin
reportedli
moder
antivir
activ
vitro
sarscov
ic
merscov
ic
ic
ic
fail
exert
antivir
effect
sarscov
mice
barnard
et
al
de
wild
et
al
shen
et
al
inhibit
viral
proteas
also
evalu
lopinavir
proteas
inhibitor
design
human
immunodefici
viru
like
chloroquin
exert
moder
antivir
effect
cov
replic
ec
valu
merscov
sarscov
de
wild
et
al
rdv
broadspectrum
antivir
drug
potent
vitro
antivir
activ
vivo
therapeut
efficaci
cov
agostini
et
al
murphi
et
al
sheahan
et
al
howev
full
breadth
activ
cov
yet
determin
previous
demonstr
antivir
activ
rdv
sarscov
relat
zoonot
batcov
beta
merscov
relat
batcov
beta
alpha
mhv
beta
agostini
et
al
sheahan
et
al
addit
parent
nucleosid
rdv
ie
prodrug
report
ec
felin
infecti
periton
viru
fip
alpha
cov
could
revers
lethal
diseas
experiment
infecti
cat
murphi
et
al
show
rdv
potent
antivir
activ
pdcov
subgenera
beta
alpha
antivir
activ
rdv
measur
cytopath
effectbas
assay
cell
celltiterglo
assay
dot
repres
data
one
well
plate
line
mean
error
bar
repres
standard
deviat
b
cytotox
rdv
measur
via
celltiterglo
assay
c
percent
inhibit
percent
cytotox
data
panel
panel
b
determin
ec
cc
five
independ
studi
perform
averag
ec
repres
data
singl
experi
shown
delta
respect
yet
test
repres
alpha
eg
pedv
gamma
eg
avian
infecti
bronchiti
viru
aibv
cov
member
similar
rdrp
like
evalu
outstand
subgenera
yet
evalu
beta
current
compris
batcov
lau
et
al
cultur
system
beta
virus
current
avail
thu
report
demonstr
potent
antivir
activ
rdv
repres
captur
near
familywid
cov
rdrp
divers
includ
deltacoronaviru
diverg
rdrp
known
cov
compar
sarsand
merscov
data
suggest
futur
emerg
cov
may
similarli
suscept
inhibit
rdv
cov
rna
replic
complex
compris
multipl
viral
protein
one
viral
rdrp
gener
nascent
genom
subgenom
viral
rna
cov
rdrp
rel
conserv
amino
acid
percent
similar
vari
antivir
drug
interact
interfer
rdrp
function
variat
amino
acid
sequenc
result
protein
structur
profound
effect
suscept
lo
et
al
recent
report
correl
nucleotid
interact
motif
b
rdrp
suscept
antivir
activ
rdv
motif
b
highli
conserv
within
viru
famili
gener
correl
rdv
antivir
activ
member
flavivirida
ie
west
nile
viru
ec
yellow
fever
viru
ec
tick
born
enceph
viru
ec
hepat
c
viru
ec
potenc
rdv
mix
even
though
motif
b
part
highli
conserv
thu
factor
rdrp
structur
function
like
mediat
discrep
mutat
identifi
passag
mhv
presenc
rdv
provid
partial
resist
rdv
antivir
activ
ie
shift
ec
respect
interestingli
though
mhv
sarscov
rdrp
ident
resist
transfer
sarscov
via
revers
genet
introduct
homolog
mutat
agostini
et
al
show
pdcov
member
deltacoronaviru
genu
exquisit
sensit
rdv
despit
natur
harbor
one
two
rdrp
resist
mutat
identifi
mhv
without
revers
genet
system
pdcov
possibl
definit
determin
homolog
mutat
alter
antivir
effect
rdv
pdcov
recent
public
describ
sarscov
rdrp
structur
author
suggest
mutat
locat
finger
domain
contact
motif
b
impact
activ
site
dynam
relat
catalysi
kirchdoerf
ward
interestingli
kirchdorf
ward
suggest
mhv
resist
mutat
sarscov
rdrp
increas
stringenc
base
pair
therebi
increas
polymeras
fidel
allow
better
exclus
rdv
activ
site
kirchdoerf
ward
futur
studi
focu
passag
pdcov
rdv
resist
determin
genet
diverg
cov
take
similar
differ
path
toward
acquir
rdv
resist
broadspectrum
approach
maxim
util
antivir
proven
efficaci
current
epidem
strain
well
zoonot
virus
like
seed
futur
emerg
describ
breadth
rdv
antivir
activ
human
zoonot
cov
found
rdv
decreas
potenc
pdcov
porcin
kidney
cell
line
although
virus
similarli
sensit
human
hepatoma
cell
although
differ
rdv
normal
uptak
metabol
report
nucleosid
analog
lamivudin
ie
tc
leung
bendayan
interestingli
uptak
antivir
activ
ribavirin
anoth
nucleosid
analog
report
vari
significantli
among
human
liver
cell
line
directli
correl
antivir
activ
polioviru
indic
variat
small
molecul
uptaketransport
impact
antivir
efficaci
ibarra
pfeiffer
rdv
alter
metabol
mice
due
circul
serum
carboxylesteras
absent
human
sheahan
et
al
potent
antivir
mhv
mous
dbt
cell
agostini
et
al
therefor
metabol
issu
rdv
specif
mous
vivo
system
although
like
cell
defici
cellular
process
requir
antivir
activ
rdv
without
test
porcin
cell
line
possibl
ascertain
whether
cell
line
specif
speci
specif
specul
potenti
efficaci
pdcov
pig
focus
effort
develop
vitro
assay
human
zoonot
cov
anim
model
exist
well
pdcov
within
vivo
efficaci
could
evalu
jung
et
al
lassnig
et
al
stjean
et
al
given
demonstr
antivir
activ
panel
cov
great
rdrp
divers
rdv
may
efficaci
futur
emerg
cov
long
fall
within
spectrum
known
genet
divers
prepar
potenti
drug
resist
singl
therapi
multipl
novel
broadspectrum
antivir
strategi
need
moreov
desir
safeti
profil
combin
broadspectrum
antivir
therapi
dispar
mechan
action
may
effect
treat
emerg
viral
syndrom
parallel
prior
etiolog
agent
identif
avail
new
antivir
therapi
would
markedli
expand
current
treatment
option
avail
clinician
current
frontlin
agent
treat
emerg
viral
epidem
ie
ribavirin
interferon
lopinavirritonavir
corticosteroid
often
improv
outcom
support
care
zumla
et
al
therefor
studi
provid
evid
antivir
activ
rdv
endem
epidem
zoonot
cov
may
use
treat
patient
sever
endem
cov
infect
merscov
patient
emerg
cov
diseas
futur
provid
drug
safeti
profil
proven
compat
use
affect
patient
popul
